Euclidean Capital as of Dec. 31, 2024
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 71.3 | $525M | 896k | 586.08 | |
| Ishares Tr Msci India Etf (INDA) | 17.3 | $128M | 2.4M | 52.64 | |
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 7.9 | $58M | 1.0M | 57.41 | |
| Oric Pharmaceuticals (ORIC) | 1.1 | $8.0M | 989k | 8.07 | |
| Foghorn Therapeutics (FHTX) | 1.0 | $7.4M | 1.6M | 4.72 | |
| Pmv Pharmaceuticals (PMVP) | 0.5 | $4.0M | 2.6M | 1.51 | |
| Alector (ALEC) | 0.3 | $2.5M | 1.3M | 1.89 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $1.5M | 1.0M | 1.43 | |
| Surrozen Com New (SRZN) | 0.2 | $1.3M | 88k | 14.35 | |
| Rapt Therapeutics | 0.1 | $1.0M | 658k | 1.58 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.7k | 171k | 0.02 |
